Riskpilot← Back to searchSign inGet full accessBiovian Oy
OYActiveY-tunnus 1808073-1Tykistökatu 6Manufacture of other chemical products n.e.c. · NACE 2059Est. 2003— employeeswww.biovian.com
Revenue 2024
EUR 30,6M
-10% vs 2023
EBITDA margin
25.8%
+15% vs 2023
Equity ratio
80.9%
Financial strength
Net profit 2024
EUR 1,6M
+7% vs 2023
| Revenue | EUR 30,6M | -10% |
| EBITDA | EUR 7,9M | +15% |
| Net profit | EUR 1,6M | +7% |
| Total assets | EUR 22,2M | -5% |
| Equity | EUR 17,9M | +9% |
| Employees | — | — |
Legal name
Biovian Oy
Y-tunnus number
1808073-1
Legal form
Osakeyhtiö
NACE code
2059 · Manufacture of other chemical products n.e.c.
Founded
27. tammikuuta 2003
Share capital
EUR 19 866
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen puheenjohtaja ja toimitusjohtaja kumpikin yksin ja hallituksen jäsenet kaksi yhdessä
Company purpose
Yhtiön toimialana on lääketeollisuus-, diagnostiikka- ja biotekniikkatuotteiden valmistus, kehitys, maahantuonti, vienti ja myynti ja näihin liittyvä konsultointi sekä validointi-, huolto-, ylläpito-, testaus-, koulutus- ja tutkimuspalvelut. Yhtiö voi toimintaansa varten ostaa ja myydä sekä vuokrata ja antaa vuokralle kiinteää omaisuutta sekä omistaa, myydä ja hallita osakkeita ja muita arvopapereita kuitenkaan ammattimaista arvopaperikauppaa tai sijoitustoimintaa harjoittamatta.
Address
Tykistökatu 6
Phone
+358022334445
Website
www.biovian.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 18 304 | 18 663 | 26 074 | 33 917 | 30 573 |
| Staff expenses | −4 854 | −6 153 | −8 688 | −11 949 | −9 721 |
| EBITDA | 5 655 | 5 343 | 5 952 | 6 876 | 7 879 |
| Depreciation & amort. | −781 | −1 277 | −1 638 | −2 681 | −2 863 |
| EBIT | 4 874 | 4 067 | 4 314 | 4 194 | 5 016 |
| Net financials | 7 | 0 | 7 | 131 | 233 |
| Profit before tax | 4 000 | 2 067 | 2 841 | 1 826 | 1 949 |
| Tax | 977 | 816 | 867 | 370 | 394 |
| Net profit | 3 023 | 1 250 | 1 973 | 1 456 | 1 555 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 14 458 | 18 488 | 22 544 | 23 268 | 22 200 |
| Equity | 11 714 | 12 964 | 14 938 | 16 394 | 17 949 |
| Long-term debt | 60 | 30 | 22 | 0 | 0 |
| Short-term debt | 2 684 | 5 494 | 7 584 | 6 874 | 4 251 |
| Total debt | 2 744 | 5 523 | 7 606 | 6 874 | 4 251 |
EBITDA margin
25.8%
This company
15.8%
Market median
+63% vs market
20202024
Equity ratio
80.9%
This company
38.2%
Market median
+112% vs market
20202024
Return on equity
8.7%
This company
18.4%
Market median
-53% vs market
20202024
Net profit margin
5.1%
This company
8.1%
Market median
-37% vs market
20202024
Asset turnover
1.38×
This company
1.12×
Market median
+23% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
PT Confidential Clerk | Confidential Clerk | 2013 |
AO Chief Executive Officer | Chief Executive Officer | 2022 |
| Former (2) | ||
KO Chief Executive Officer | Chief Executive Officer | 2013 – 2022 |
TT Audit | Audit | 2018 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Board of Directors | 2024 | |
| Former (10) | ||
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2018 – 2019 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2023 – 2024 | |
| Board of Directors | 2022 – 2024 | |
| Board of Directors | 2018 – 2023 | |
| Board of Directors | 2022 – 2024 | |
| Chairperson | 2018 – 2024 | |
| Board of Directors | 2018 – 2024 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Biovian Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Knut Olof Ringbom | Chief Executive Officer | 0 companies |
| Pirkko Taina Kortteinen | Confidential Clerk | 0 companies |
| Tomi Tapani Moisio | Audit | 0 companies |
| Antti Olavi Nieminen | Chief Executive Officer | 0 companies |
| Vincent Manès | Board of Directors | 0 companies |
| Magdalena Maria Sacre Svensson | Board of Directors | 0 companies |
| Jari Olavi Saarinen | Board of Directors | 0 companies |
| Jani Ilmari Yömaa | Board of Directors | 0 companies |
| David Piccoli | Board of Directors | 0 companies |
| Uwe Gottschalk | Board of Directors | 0 companies |
| Jaana Elina Grüter | Board of Directors | 0 companies |
| Damaso Molero Sanchez | Board of Directors | 0 companies |
| Carl Magnus Berthold Gustafsson | Board of Directors | 0 companies |
| Pierre Andre Jean-Marie Remy | Chairperson | 0 companies |
| Nicolas Bernard Pascal Marie Ulrich | Board of Directors | 0 companies |